scholarly journals THE IMPACT OF SLEEP DISORDERS ON THE ATTENTION DEFICIT DISORDER IN THE ADULTPART II: THE NON-OSA PATIENT

CHEST Journal ◽  
2005 ◽  
Vol 128 (4) ◽  
pp. 384S
Author(s):  
Clifford G. Risk ◽  
Nadine Y. Smith
Keyword(s):  
Sleep Disorders ◽  
Attention Deficit ◽  
Attention Deficit Disorder ◽  
The Impact

scholarly journals How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHD

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Reiner Buchhorn ◽  
Christian Müller ◽  
Christian Willaschek ◽  
Kambiz Norozi
Keyword(s):  
Sudden Cardiac Death ◽  
Attention Deficit ◽  
Attention Deficit Disorder ◽  
Cardiac Death ◽  
Control Group ◽  
Healthy Children ◽  
Children With Adhd ◽  
Heart Defect ◽  
Adhd Children ◽  
The Impact

Background. Although stimulants have long been touted as treatments for attention deficit disorder with or without hyperactivity (ADHD), in recent years, increasing concerns have been raised about the cardiovascular safety of these medications. We aimed to prove if measurements of autonomic function with time domain analysis of heart rate variability (HRV) in 24-hour Holter ECG are useful to predict the risk of sudden cardiac death in ADHD children and adolescents. Methods. We analysed HRV obtained from children with the diagnosis of ADHD prior to (N=12) or during medical therapy (N=19) with methylphenidate (MPH), aged 10.8±2.0 years (mean ± SD), who were referred to our outpatient Paediatric Cardiology Clinic to rule out heart defect. As a control group, we compared the HRV data of 19 age-matched healthy children without heart defect. Results. Average HRV parameters from 24-hour ECG in the ADHD children prior to MPH showed significant lower values compared to healthy children with respect to rMSSD (26±4 ms versus 44±10 ms, P≤0.0001) and pNN50 (6.5±2.7% versus 21.5±9.0%, P≤0.0001). These values improved in MPH-treated children with ADHD (RMSSD: 36±8 ms; pNN50: 14.2±6.9%). Conclusion. Children who suffer from ADHD show significant changes in HRV that predominantly reflects diminished vagal tone, a well-known risk factor of sudden cardiac death in adults. In our pilot study, MPH treatment improved HRV.

scholarly journals The Impact of MNRI Therapy on the Levels of Neurotransmitters Associated with Inflammatory Processes

2020 ◽  
Vol 21 (4) ◽  
pp. 1358 ◽  
Author(s):  
Tatiana V. Tatarinova ◽  
Trina Deiss ◽  
Lorri Franckle ◽  
Susan Beaven ◽  
Jeffrey Davis
Keyword(s):  
Attention Deficit ◽  
Attention Deficit Disorder ◽  
Emotional Regulation ◽  
Cognitive Skills ◽  
Developmental Disorders ◽  
Negative Impact ◽  
Autism Spectrum ◽  
Post Traumatic Stress ◽  
Compulsive Disorder ◽  
The Impact

The neurotransmitter levels of representatives from five different diagnosis groups were tested before and after participation in the MNRI®—Masgutova Neurosensorimotor Reflex Intervention. The purpose of this study was to ascertain neurological impact on (1) Developmental disorders, (2) Anxiety disorders/OCD (Obsessive Compulsive Disorder), PTSD (Post-Traumatic Stress disorder), (3) Palsy/Seizure disorders, (4) ADD/ADHD (Attention Deficit Disorder/Attention Deficit Disorder Hyperactive Disorder), and (5) ASD (Autism Spectrum Disorder) disorders. Each participant had a form of neurological dysregulation and typical symptoms respective to their diagnosis. These diagnoses have a severe negative impact on the quality of life, immunity, stress coping, cognitive skills, and social assimilation. This study showed a trend towards optimization and normalization of neurological and immunological functioning, thus supporting the claim that the MNRI method is an effective non-pharmacological neuromodulation treatment of neurological disorders. The effects of MNRI on inflammation have not yet been assessed. The resulting post-MNRI changes in participants’ neurotransmitters show significant adjustments in the regulation of the neurotransmitter resulting in being calmer, a decrease of hypervigilance, an increase in stress resilience, behavioral and emotional regulation improvements, a more positive emotional state, and greater control of cognitive processes. In this paper, we demonstrate that the MNRI approach is an intervention that reduces inflammation. It is also likely to reduce oxidative stress and encourage homeostasis of excitatory neurotransmitters. MNRI may facilitate neurodevelopment, build stress resiliency, neuroplasticity, and optimal learning opportunity. There have been no reported side effects of MNRI treatments.

scholarly journals The Impact of Neurofeedback on Clinical Signs of Children That Have Attention Deficit Disorder and Hyperactivity

2017 ◽  
Vol 9 (2) ◽  
pp. 48
Author(s):  
Samaneh Hedayati Manesh ◽  
Azam Alikhademi
Keyword(s):  
Attention Deficit ◽  
Attention Deficit Disorder ◽  
Clinical Signs ◽  
The Other ◽  
Control Group ◽  
Wait List ◽  
Other Hand ◽  
Adhd Children ◽  
The Impact ◽  
Experimental Group

This study was an attempt to examine the impact of Neurofeedback on clinical signs of Children that have attention deficit disorder and hyperactivity. The participants of this study 24 boys (6-11) that afflicted to ADHD. The participants of the study randomly divided into two groups and were selected to participate in the study. The experimental group received the Neurofeedback treatment (8 weeks, three sessions in a week). The control group, on the other hand was placed in a wait list. After treatment, CBCL, IVA, QEEG were administered between two groups. The analysis of data revealed that Nero feedback has a significant impact on ADHD children. Moreover, Neurofeedback treatment leads to improve attention deficit disorder and decrease impulsivity in ADHD children.

The Non-Impact of Paper Color on Exam Performance

2012 ◽  
Vol 27 (3) ◽  
pp. 691-706 ◽  
Author(s):  
Michael J. Meyer ◽  
Jennifer Bagwell
Keyword(s):  
Attention Deficit ◽  
Student Motivation ◽  
Attention Deficit Disorder ◽  
Exam Performance ◽  
Final Exam ◽  
Hyperactivity Disorder ◽  
Time Period ◽  
Final Exams ◽  
Colored Paper ◽  
The Impact

ABSTRACT This study attempts to determine if the conclusions of Fordham and Hayes (2009) can be confirmed to include exam performance (they study only quiz performance) by examining the impact of paper color on student final exam performance. One thousand three hundred seventy-two final exams were evaluated covering ten academic quarters, from the Winter 2007 through the Winter 2011. Over this time period, eight different paper colors were used, including seven pastel colors and white. The results show that paper color has no impact on student exam performance and that paper color and student exam performance are independent factors. If we assume that students are motivated to take a final exam and less so to take a quiz, then student motivation (as per Soldat et al. 1997) may be a plausible explanation for the differing results between this study and Fordham and Hayes (2009). The results of this study suggest there may not be a need to restrict the use of pastel paper color on exams, although we describe some evidence and opinions that suggest certain paper colors, including white, may impact those with certain disabilities (i.e., dyslexia, Attention Deficit Disorder [ADD], and Attention Deficit Hyperactivity Disorder [ADHD]). Further, we determine that the widespread use of colored paper may be somewhat of a U.S. phenomenon.

scholarly journals Utility of Repeated Assessment After Invalid Baseline Neurocognitive Test Performance

2014 ◽  
Vol 49 (5) ◽  
pp. 659-664 ◽  
Author(s):  
Philip Schatz ◽  
Timothy Kelley ◽  
Summer D. Ott ◽  
Gary S. Solomon ◽  
R. J. Elbin ◽  
...  
Keyword(s):  
Reaction Time ◽  
Learning Disability ◽  
Attention Deficit ◽  
Attention Deficit Disorder ◽  
Neurocognitive Testing ◽  
History Of ◽  
Baseline Test ◽  
The Impact ◽  
Repeated Assessment

Context: Although the prevalence of invalid baseline neurocognitive testing has been documented, and repeated administration after obtaining invalid results is recommended, no empirical data are available on the utility of repeated assessment after obtaining invalid baseline results. Objective: To document the utility of readministering neurocognitive testing after an invalid baseline test. Design: Case series. Setting: Schools, colleges, and universities. Patients or Other Participants: A total of 156 athletes who obtained invalid results on ImPACT baseline neurocognitive testing and were readministered the ImPACT baseline test within a 2-week period (mean = 4 days). Main Outcome Measure(s): Overall prevalence of invalid results on reassessment, specific invalidity indicators at initial and follow-up baseline, dependent-samples analysis of variance, with Bonferroni correction for multiple comparisons. Results  Reassessment resulted in valid test results for 87.2% of the sample. Poor performance on the Design Memory and Three-Letter subscales were the most common reasons for athletes obtaining an invalid baseline result, on both the initial assessment and the reassessment. Significant improvements were noted on all ImPACT composite scores except for Reaction Time on reassessment. Of note, 40% of athletes showed slower reaction time scores on reassessment, perhaps reflecting a more cautious approach taken the second time. Invalid results were more likely to be obtained by athletes with a self-reported history of attention-deficit disorder or learning disability on reassessments (35%) than on initial baseline assessments (10%). Conclusions: Repeat assessment after the initial invalid baseline performance yielded valid results in nearly 90% of cases. Invalid results on a follow-up assessment may be influenced by a history of attention-deficit disorder or learning disability, the skills and abilities of the individual, or a particular test-taking approach; in these cases, a third assessment may not be useful.

Sign in / Sign up

Export Citation Format

Share Document